Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

ACE Announces Increase In Professional Liability Coverage For Podiatrists

RELATED NEWS
Trade ACE now with 

Swiss-based insurer ACE Limited's (ACE: Quote) U.S. based retail operations ACE USA said Friday that its ACE Medical Risk Division has increased the reimbursement limits for legal expenses incurred due to an action by a federal or state agency arising from a podiatrist's pariticipation in the Medicare or Medicaid programs.

The company said the new Podiatrist Professional Liability Coverage Endorsement will help to mitigate and manage rising legal expenses by raising the coverage limits from $30,000 to $50,000 per action, with an annual aggregate of $50,000.

The product is underwritten by companies within the ACE Group and is offered to podiatrists exclusively by RPS Healthcare, National Program Administrator of the Podiatry PLUS program.

This new product enhancement comes to the market as ACE and RPS prepare for their participation in the 2012 Midwest Podiatry Conference in Chicago, Illinois.

Click here to receive FREE breaking news email alerts for ACE Limited and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
This apparel maker has doubled its earnings per share in just two years and increased its annual earnings forecast from time to time, despite a challenging consumer spending environment. Contributions from acquisitions, efficiency gains from self-owned global supply chain and benefits from 'Innovate-to-Elevate' strategy continue to boost the company's results. Here is a quick summary of the earnings reported after the bell on Nov 20. We have 20+ stocks listed here. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed... Design software maker Autodesk, Inc. said Thursday after the markets closed that its third quarter profit fell 81% from last year, as higher costs and expenses more than offset an 11% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.